The University of Chicago Header Logo

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement. Laryngoscope. 2021 06; 131(6):E1941-E1949.

View in: PubMed